At one point, I was unable to fill my prescription for weeks because there was a run on the product
GLP-1 agonists reduce appetite, modulate satiety circuits, alter hepatic lipid handling, improve endothelial function, attenuate inflammatory tone, influence microglial behavior, and appear to exert downstream neuroprotective effects, yet the field cannot convincingly articulate how these effects relate to one another, which are primary versus secondary, or which are merely correlative epiphenomena arising from broader systemic shifts
Currently, most insurance coverage for GLP-1 RAs is limited to patients with type 2 diabetes, although their use for cardiovascular risk reduction in non-diabetic patients continues to gain support from clinical evidence [21]
Schwandt, Hans-Joachim (2019)
Through microbial fermentation involving reactions like hydrolysis, oxidation, decarboxylation, and reduction, they are converted into smaller molecules, thereby improving oral bioavailability [108]